Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease

Acta Ophthalmologica

Volumn 94, Issue 6, 2016, Pages e454-e459

  Garcia Martin, Elena ^a,b   Bambo, Maria P ^a,b   Marques, Marcia L ^c   Satue, Maria ^a,b   Otin, Sofia ^a,b   Larrosa, Jose M ^a,b   Polo, Vicente ^a,b   Pablo, Luis E ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c Ocular Discomfort Institute   (Brazil)

Author keywords

Alzheimer's disease; biomarker; optical coherence tomography; retinal nerve fibre layer; retinal segmentation

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE SEGMENTATION; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NERVE INJURY; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA MACULA LUTEA; RETINA NERVE CELL; RETINAL INNER PLEXIFORM LAYER; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL OUTER NUCLEAR LAYER; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

EID: 84984666929     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12977     Document Type: Article

References (31)

1. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C & Kiss S (2010): Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4: 1427–1432.
2. Albrecht P, Müller AK, Südmeyer M et al. (2012a): Optical coherence tomography in parkinsonian syndromes. PLoS One 7: e34891.
3. Albrecht P, Ringelstein M, Müller AK et al. (2012b): Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 18: 1422–1429.
4. Bambo MP, Garcia-Martin E, Pinilla J et al. (2014): Detection of retinal nerve fiber layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers. Acta Ophthalmol 92: e581–e582.
5. Bambo MP, Garcia-Martin E, Otin S, Pinilla J, Larrosa JM, Polo V & Pablo LE (2015): Visual function and retinal nerve fibre layer degeneration in patients with Alzheimer disease: correlations with severity of dementia. Acta Ophthalmol 93: e507–e508.
6. Canu E, Agosta F, Spinelli EG et al. (2013): White matter microstructural damage in Alzheimer's disease at different ages of onset. Neurobiol Aging 34: 2331–2340.
7. Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL & Balcer LJ (2011): Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol 31: 260–264.
8. Einarsdottir A, Hardarson SH, Kristjansdottir JV, Bragason DT, Snaedal J & Stefánsson E (2015): Retinal oximetry imaging in Alzheimer's disease. J Alzheimers Dis 49: 79–83.
9. Ekström C & Kilander L (2014): Pseudoexfoliation and Alzheimer's disease: a population-based 30-year follow-up study. Acta Ophthalmol 92: 355–358.
10. Ewers M, Sperling RA, Klunk WE, Weiner MW & Hampel H (2011): Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci 34: 430–442.
11. Folstein MF, Folstein SE & McHugh PR (1975): Mini-Mental State Examination: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
12. Garcia-Martin E, Pueyo V, Almarcegui C et al. (2011): Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 95: 1577–1582.
13. Garcia-Martin E, Pablo LE, Herrero R, Satue M, Polo V, Larrosa JM, Martin J & Fernandez J (2012): Diagnostic ability of a linear discriminant function for Spectral domain optical coherence tomography in multiple sclerosis patients. Ophthalmology 119: 1705–1711.
14. Garcia-Martin E, Rodriguez-Mena D, Herrero R et al. (2013): Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS. Neurology 81: 76–83.
15. Garcia-Martin E, Polo V, Larrosa JM et al. (2014): Retinal layer segmentation in multiple sclerosis patients using spectral domain optical coherence tomography. Ophthalmology 121: 573–579.
16. Gordon-Lipkin E, Chodkowski B, Reich DS et al. (2007): Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69: 1603–1639.
17. Hof PR & Morrison JH (1990): Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J Comp Neurol 301: 55–64.
18. Iseri PK, Altinaş O, Tokay T & Yüksel N (2006): Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26: 18–24.
19. Jentsch S, Schweitzer D, Schmidtke KU, Peters S, Dawczynski J, Bär KJ & Hammer M (2015): Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease. Acta Ophthalmol 93: e241–e247.
20. Jindahra P, Petrie A & Plant GT (2009): Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 132(Pt 3): 628–634.
21. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E & Neudorfer M (2011): Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 113: 523–526.
22. Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C & Staurenghi G (2013): Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54: 5953–5958.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D & Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944.
24. Mungas D (1991): In-office mental status testing: a practical guide. Geriatrics 46: 54–58.
25. Pangman VC, Sloan J & Guse L (2000): An examination of psychometric properties of the Mini-Mental State Examination and the Standardized Mini-Mental State Examination: implications for clinical practice. Appl Nurs Res 13: 209–213.
26. Polo V, Garcia-Martin E, Bambo MP, Pinilla J, Larrosa JM, Satue M, Otin S & Pablo LE (2014): Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease. Eye (Lond) 28: 680–690.
27. Reich DS, Smith SA, Gordon-Lipkin EM, Ozturk A, Caffo BS, Balcer LJ & Calabresi PA (2009): Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol 66: 998–1006.
28. Sadun AA, Borchert M, DeVita E, Hinton DR & Bassi CJ (1987): Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol 104: 113–120.
29. Schuman JS, Pedut-Kloizman T, Hertzmark E et al. (1996): Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology 103: 1889–1898.
30. Tas A, Yolcu U, Ilhan A & Gundogan FC (2015): Detection of retinal nerve fibre layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers. Acta Ophthalmol 93: e507.
31. Valenti DA (2010): Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease. Int J Alzheimers Dis 2010: 793931.